natgillin/translations-raw huggingface dataset:
Commission Directive 91/376/EEC
Direktiva Komisije 91/376/EGS
(OJ L 203, 26.7.1991, p. 108)
(UL L 203, 26.7.1991, str. 108)
75/502/EEC
75/502/EGS
1 July 1976
1 julij 1976
86/109/EEC
86/109/EGS
1 July 1987 (Article 1)
1 julij 1987 (člen 1)
1 July 1989 (Article 2)
1 julij 1989 (člen 2)
1 July 1990 (Article 2a)
1 julij 1990 (člen 2a)
1 July 1991 (Articles 3 and 3a)
1 julij 1991 (člen 3 in 3a)
89/424/EEC
89/424/EGS
1 July 1990
1 julij 1990
91/376/EEC
91/376/EGS
1 July 1991
1 julij 1991
Directive 75/502/EEC
Direktiva 75/502/EEC
Directive 86/109/EEC
Direktiva 86/109/EEC
Article 3a(2) to (6)
Člen 3a(2) do (6)
Lupinus angustifolius L.
Lupinus Augustifolius L.
Merr.
Merr
Commission Directive 2008/125/EC
Direktiva Komisije 2008/125/ES
of 19 December 2008
z dne 19. decembra 2008
amending Council Directive 91/414/EEC to include aluminium phosphide, calcium phosphide, magnesium phosphide, cymoxanil, dodemorph, 2,5-dichlorobenzoic acid methylester, metamitron, sulcotrione, tebuconazole and triadimenol as active substances
o spremembi Direktive Sveta 91/414/EGS zaradi vključitve aluminijevega fosfida, kalcijevega fosfida, magnezijevega fosfida, cimoksanila, dodemorfa, metilestra 2,5-diklorobenzojske kisline, metamitrona, sulkotriona, tebukonazola in triadimenola kot aktivnih snovi
That list includes aluminium phosphide, calcium phosphide, magnesium phosphide, cymoxanil, dodemorph, 2,5-dichlorobenzoic acid methylester, metamitron, sulcotrione, tebuconazole and triadimenol.
Navedeni seznam vključuje aluminijev fosfid, kalcijev fosfid, magnezijev fosfid, cimoksanil, dodemorf, metilester 2,5-diklorobenzojske kisline, metamitron, sulkotrion, tebukonazol in triadimenol.
For aluminium phosphide, calcium phosphide, magnesium phosphide, 2,5-dichlorobenzoic acid methylester and sulcotrione the rapporteur Member State was Germany and all relevant information was submitted on 19 June 2007 for aluminium phosphide, calcium phosphide, magnesium phosphide and 2,5-dichlorobenzoic acid methylester and on 9 August 2006 for sulcotrione.
Država članica poročevalka za aluminijev fosfid, kalcijev fosfid, magnezijev fosfid, metilester 2,5-diklorobenzojske kisline in sulkotrion je bila Nemčija, vse ustrezne informacije pa so bile predložene 19. junija 2007 za aluminijev fosfid, kalcijev fosfid, magnezijev fosfid in metilester 2,5-diklorobenzojske kisline ter 9. avgusta 2006 za sulkotrion.
For metamitron, and triadimenol the rapporteur Member State was the United Kingdom and all relevant information was submitted on 22 August 2007 and 29 May 2006 respectively.
Država članica poročevalka za metamitron in triadimenol je bila Združeno kraljestvo, vse ustrezne informacije pa so bile predložene 22. avgusta 2007 in 29. maja 2006 v tem zaporedju.
For cymoxanil, the rapporteur Member State was Austria and all relevant information was submitted on 15 June 2007.
Država članica poročevalka za cimoksanil je bila Avstrija, vse ustrezne informacije pa so bile predložene 15. junija 2007.
For dodemorph, the rapporteur Member State was the Netherlands and all relevant information was submitted on 9 February 2007.
Država članica poročevalka za dodemorf je bila Nizozemska, vse ustrezne informacije pa so bile predložene 9. februarja 2007.
For tebuconazole the rapporteur Member State was Denmark and all relevant information was submitted on 5 March 2007.
Država članica poročevalka za tebukonazol je bila Danska, vse ustrezne informacije pa so bile predložene 5. marca 2007.
The assessment reports have been peer reviewed by the Member States and the EFSA and presented to the Commission on 29 September 2008 for aluminium phosphide, calcium phosphide and metamitron, on 30 September 2008 for magnesium phosphide, on 17 September 2008 for cymoxanil and dodemorph, on 26 September 2008 for 2,5-dichlorobenzoic acid methylester, on 31 July 2008 for sulcotrione and on 25 September 2008 for tebuconazole and triadimenol in the format of the EFSA Scientific Reports [4].
Poročila o oceni so pregledali strokovnjaki držav članic in EFSA ter jih predložili Komisiji v obliki znanstvenih poročil EFSA, in sicer 29. septembra 2008 za aluminijev fosfid, kalcijev fosfid in metamitron, 30. septembra 2008 za magnezijev fosfid, 17. septembra 2008 za cimoksanil in dodemorf, 26. septembra 2008 za metilester 2,5-diklorobenzojske kisline, 31. julija 2008 za sulkotrion in 25. septembra 2008 za tebukonazol in triadimenol [4].
These reports have been reviewed by the Member States and the Commission within the Standing Committee on the Food Chain and Animal Health and finalised on 28 October 2008 in the format of the Commission review reports for aluminium phosphide, calcium phosphide, magnesium phosphide, cymoxanil, dodemorph, 2,5-dichlorobenzoic acid methylester, metamitron, sulcotrione, tebuconazole and triadimenol.
Ta poročila so države članice in Komisija pregledale v okviru Stalnega odbora za prehranjevalno verigo in zdravje živali ter končno različico pripravile 28. oktobra 2008 v obliki poročil Komisije o pregledu za aluminijev fosfid, kalcijev fosfid, magnezijev fosfid, cimoksanil, dodemorf, metilester 2,5-diklorobenzojske kisline, metamitron, sulkotrion, tebukonazol in triadimenol.
It has appeared from the various examinations made that plant protection products containing aluminium phosphide, calcium phosphide, magnesium phosphide, cymoxanil, dodemorph, 2,5-dichlorobenzoic acid methylester, metamitron, sulcotrione, tebuconazole or triadimenol may be expected to satisfy, in general, the requirements laid down in Article 5(1)(a) and (b) of Directive 91/414/EEC, in particular with regard to the uses which were examined and detailed in the Commission review reports.
Različne preiskave so pokazale, da se za fitofarmacevtska sredstva, ki vsebujejo aluminijev fosfid, kalcijev fosfid, magnezijev fosfid, cimoksanil, dodemorf, metilester 2,5-diklorobenzojske kisline, metamitron, sulkotrion, tebukonazol ali triadimenol, lahko pričakuje, da na splošno izpolnjujejo zahteve iz člena 5(1)(a) in (b) Direktive 91/414/EGS, zlasti v zvezi z uporabami, ki so bile proučene in podrobno navedene v poročilih Komisije o pregledu.
It is therefore appropriate to include these active substances in Annex I, in order to ensure that in all Member States the authorisations of plant protection products containing these active substances can be granted in accordance with the provisions of that Directive.
Zato je primerno te aktivne snovi vključiti v Prilogo I, da se v vseh državah članicah v skladu z določbami navedene direktive lahko registrirajo fitofarmacevtska sredstva, ki vsebujejo te aktivne snovi.
Therefore, it is appropriate for metamitron to require the notifier to submit further information as regards the impact of soil metabolite M3 on groundwater, on residues in rotational crops, on the long term risk to insectivorous birds and on the specific risk to birds and mammals that may be contaminated by the intake of water in field.
Zato je primerno, da se za metamitron od prijavitelja zahteva predložitev dodatnih informacij v zvezi z vplivom metabolita M3 v tleh na podtalnico, ostanke pri posevkih, gojenih v kolobarju, na dolgoročno tveganje za žužkojede ptice ter posebno tveganje za ptice in sesalce, ki se lahko okužijo z zaužitjem vode na poljih.
Furthermore, for sulcotrione it is appropriate to require the notifier to submit further information as regards the degradation in soil and water of the cyclohexadione moiety and the long term risk to insectivorous birds.
Poleg tega je za sulkotrion od prijavitelja primerno zahtevati predložitev dodatnih informacij v zvezi z razgradnjo deleža cikloheksadiona v zemlji in vodi ter dolgoročnim tveganjem za žužkojede ptice.
In addition, it is appropriate to require that tebuconazole should be subjected to further testing for the confirmation of the risk assessment for birds and mammals and such information should be presented by the notifier.
Prav tako je primerno zahtevati, da se za tebukonazol izvedejo dodatna testiranja za potrditev ocene tveganja za ptice in sesalce, takšne informacije pa mora predstaviti prijavitelj.
Moreover, it is appropriate to require that tebuconazole and triadimenol be subjected to further testing of their potential endocrine disrupting properties, as soon as OECD test guidelines on endocrine disruption, or, alternatively, Community agreed test guidelines exist.
Poleg tega je primerno zahtevati, da se za tebukonazol in triadimenol izvedejo dodatna testiranja glede potencialnih motenj endokrinega sistema, ki jih ti snovi povzročata, takoj ko bodo na voljo smernice OECD za preizkušanje motenj endokrinega sistema ali smernice za preizkušanje, sprejete na ravni Skupnosti.
Finally, it is appropriate to require that triadimenol should be subjected to further testing for confirmation of the chemical specification and the long risk to birds and mammals and that such information should be presented by the notifier.
Nazadnje je primerno zahtevati, da se za triadimenol izvedejo dodatna testiranja za potrditev kemijske specifikacije in dolgoročnega tveganja za ptice in sesalce, takšne informacije pa mora predstaviti prijavitelj.
Without prejudice to the obligations defined by Directive 91/414/EEC as a consequence of including an active substance in Annex I, Member States should be allowed a period of six months after inclusion to review existing authorisations of plant protection products containing aluminium phosphide, calcium phosphide, magnesium phosphide, cymoxanil, dodemorph, 2,5-dichlorobenzoic acid methylester, metamitron, sulcotrione, tebuconazole and triadimenol to ensure that the requirements laid down by Directive 91/414/EEC, in particular in its Article 13 and the relevant conditions set out in Annex I, are satisfied. Member States should vary, replace or withdraw, as appropriate, existing authorisations, in accordance with the provisions of Directive 91/414/EEC.
Brez poseganja v obveznosti iz Direktive 91/414/EGS, ki izhajajo iz vključitve aktivne snovi v Prilogo I, je treba državam članicam omogočiti, da v šestih mesecih po vključitvi snovi pregledajo obstoječe registracije fitofarmacevtskih sredstev, ki vsebujejo aluminijev fosfid, kalcijev fosfid, magnezijev fosfid, cimoksanil, dodemorf, metilester 2,5-diklorobenzojske kisline, metamitron, sulkotrion, tebukonazol in triadimenol, da zagotovijo izpolnjevanje zahtev iz Direktive 91/414/EGS, zlasti člena 13 in ustreznih pogojev iz Priloge I. Države članice v skladu z določbami Direktive 91/414/EGS obstoječe registracije po potrebi spremenijo, nadomestijo ali prekličejo.
Member States shall adopt and publish by 28 February 2010 at the latest the laws, regulations and administrative provisions necessary to comply with this Directive.
Države članice sprejmejo in objavijo zakone in druge predpise, potrebne za uskladitev s to direktivo, najpozneje do 28. februarja 2010.
They shall apply those provisions from 1 March 2010.
Navedene predpise uporabljajo od 1. marca 2010.
Member States shall in accordance with Directive 91/414/EEC, where necessary, amend or withdraw existing authorisations for plant protection products containing aluminium phosphide, calcium phosphide, magnesium phosphide, cymoxanil, dodemorph, 2,5-dichlorobenzoic acid methylester, metamitron, sulcotrione, tebuconazole and triadimenol as active substances by 28 February 2010.
Države članice v skladu z Direktivo 91/414/EGS do 28. februarja 2010 po potrebi spremenijo ali prekličejo obstoječe registracije fitofarmacevtskih sredstev, ki vsebujejo aluminijev fosfid, kalcijev fosfid, magnezijev fosfid, cimoksanil, dodemorf, metilester 2,5-diklorobenzojske kisline, metamitron, sulkotrion, tebukonazol in triadimenol kot aktivne snovi.
By that date they shall in particular verify that the conditions in Annex I to that Directive relating to aluminium phosphide, calcium phosphide, magnesium phosphide, cymoxanil, dodemorph, 2,5-dichlorobenzoic acid methylester, metamitron, sulcotrione, tebuconazole and triadimenol are met, with the exception of those identified in part B of the entry concerning that active substance, and that the holder of the authorisation has, or has access to, a dossier satisfying the requirements of Annex II to that Directive in accordance with the conditions of Article 13 of that Directive.
Do navedenega datuma zlasti preverijo, ali so pogoji iz Priloge I k navedeni direktivi v zvezi z aluminijevim fosfidom, kalcijevim fosfidom, magnezijevim fosfidom, cimoksanilom, dodemorfom, metilestrom 2,5-diklorobenzojske kisline, metamitronom, sulkotrionom, tebukonazolom in triadimenolom, z izjemo tistih iz dela B besedila o navedeni aktivni snovi, izpolnjeni in ali ima imetnik registracije dokumentacijo ali dostop do dokumentacije, ki izpolnjuje zahteve iz Priloge II k navedeni direktivi v skladu s pogoji iz člena 13 navedene direktive.
By way of derogation from paragraph 1, for each authorised plant protection product containing aluminium phosphide, calcium phosphide, magnesium phosphide, cymoxanil, dodemorph, 2,5-dichlorobenzoic acid methylester, metamitron, sulcotrione, tebuconazole and triadimenol as either the only active substance or as one of several active substances all of which were listed in Annex I to Directive 91/414/EEC by 31 August 2009 at the latest, Member States shall re-evaluate the product in accordance with the uniform principles provided for in Annex VI to Directive 91/414/EEC, on the basis of a dossier satisfying the requirements of Annex III to that Directive and taking into account part B of the entry in Annex I to that Directive concerning aluminium phosphide, calcium phosphide, magnesium phosphide, cymoxanil, dodemorph, 2,5-dichlorobenzoic acid methylester, metamitron, sulcotrione, tebuconazole and triadimenol respectively.
Z odstopanjem od odstavka 1 države članice znova ocenijo vsako registrirano fitofarmacevtsko sredstvo, ki vsebuje aluminijev fosfid, kalcijev fosfid, magnezijev fosfid, cimoksanil, dodemorf, metilester 2,5-diklorobenzojske kisline, metamitron, sulkotrion, tebukonazol in triadimenol kot edino aktivno snov ali kot eno od več aktivnih snovi, vključenih v Prilogo I k Direktivi 91/414/EGS najpozneje do 31. avgusta 2009, v skladu z enotnimi načeli iz Priloge VI k Direktivi 91/414/EGS na podlagi dokumentacije, ki izpolnjuje zahteve iz Priloge III k navedeni direktivi, in ob upoštevanju dela B besedila o aluminijevem fosfidu, kalcijevem fosfidu, magnezijevem fosfidu, cimoksanilu, dodemorfu, metilestru 2,5-diklorobenzojske kisline, metamitronu, sulkotrionu, tebukonazolu ali triadimenolu v tem zaporedju iz Priloge I k navedeni direktivi.
in the case of a product containing aluminium phosphide, calcium phosphide, magnesium phosphide, cymoxanil, dodemorph, 2,5-dichlorobenzoic acid methylester, metamitron, sulcotrione, tebuconazole or triadimenol as the only active substance, where necessary, amend or withdraw the authorisation by 28 February 2014 at the latest; or
če sredstvo vsebuje aluminijev fosfid, kalcijev fosfid, magnezijev fosfid, cimoksanil, dodemorf, metilester 2,5-diklorobenzojske kisline, metamitron, sulkotrion, tebukonazol ali triadimenol kot edino aktivno snov, najpozneje do 28. februarja 2014 po potrebi spremenijo ali prekličejo registracijo ali
in the case of a product containing aluminium phosphide, calcium phosphide, magnesium phosphide, cymoxanil, dodemorph, 2,5-dichlorobenzoic acid methylester, metamitron, sulcotrione, tebuconazole or triadimenol as one of several active substances, where necessary, amend or withdraw the authorisation by 28 February 2014 or by the date fixed for such an amendment or withdrawal in the respective Directive or Directives which added the relevant substance or substances to Annex I to Directive 91/414/EEC, whichever is the latest.
če sredstvo vsebuje aluminijev fosfid, kalcijev fosfid, magnezijev fosfid, cimoksanil, dodemorf, metilester 2,5-diklorobenzojske kisline, metamitron, sulkotrion, tebukonazol ali triadimenol kot eno izmed več aktivnih snovi, registracijo po potrebi spremenijo ali prekličejo najpozneje do 28. februarja 2014 ali do datuma, določenega za takšno spremembo ali preklic v ustreznih direktivah, s katerimi so bile zadevne snovi dodane v Prilogo I k Direktivi 91/414/EGS, pri čemer se upošteva poznejši datum.
This Directive shall enter into force on 1 September 2009.
Ta direktiva začne veljati 1. septembra 2009.
Done at Brussels, 19 December 2008.
V Bruslju, 19. decembra 2008
Common Name, Identification Numbers
Splošno ime, Identifikacijske številke
CAS No 20859-73-8
Št. CAS 20859-73-8
CIPAC No 227
Št. CIPAC 227
31 August 2019
avgust 2019
Only uses as insecticide and rodenticide in the form of ready-to-use aluminium phosphide containing products may be authorised.
Registrira se lahko samo kot insekticid in rodenticid v obliki proizvodov, ki so pripravljeni za uporabo in vsebujejo aluminijev fosfid.
As rodenticide only outdoor uses may be authorised.
Kot rodenticid se lahko registrira samo za uporabo na prostem.
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on aluminium phosphide, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 28 October 2008 shall be taken into account.
Za izvajanje enotnih načel iz Priloge VI se upoštevajo sklepi poročila o pregledu za aluminijev fosfid ter zlasti dodatkov I in II h končni različici poročila, ki jo je Stalni odbor za prehranjevalno verigo in zdravje živali pripravil 28. oktobra 2008.
the protection of consumers and ensure that the spent ready-to-use aluminium phosphide containing products are removed from the food commodity in uses against storage pests and subsequently an adequate additional withholding period is applied;
varstvo potrošnikov in zagotovitev, da se izrabljeni proizvodi, ki so pripravljeni za uporabo in vsebujejo aluminijev fosfid, pri uporabah proti škodljivcem v skladiščih odstranijo iz živila in da se naknadno uvede ustrezno dodatno obdobje prepovedi uporabe;
the operator and worker safety and ensure that conditions of use prescribe the application of adequate personal and respiratory protective equipment;
varnost izvajalcev tretiranja in delavcev ter zagotovitev, da je v pogojih uporabe predpisana uporaba ustrezne osebne zaščitne opreme in opreme za zaščito dihal;
the protection of operators and workers during fumigation for indoor uses;
varstvo izvajalcev tretiranja in delavcev med zaplinjevanjem pri uporabah v zaprtem prostoru;
the protection of workers at re-entry (after fumigation period) for indoor uses;
varstvo delavcev pri ponovnem vstopu (po obdobju zaplinjevanja) pri uporabah v zaprtem prostoru;
the protection of bystanders against leaking of gas for indoor uses;
varstvo drugih navzočih oseb pred uhajanjem plina pri uporabah v zaprtem prostoru;
the protection of birds and mammals.
zaščito ptic in sesalcev.
Conditions of authorisation should include risk mitigation measures, such as the closure of the burrows and the achievement of complete incorporation of granules in the soil, where appropriate;
Pogoji registracije morajo po potrebi vključevati ukrepe za zmanjšanje tveganja, kot so zaprtje vkopov in zagotovitev popolnega vnosa zrn v zemljo;
Conditions of authorisation should include risk mitigation measures, such as buffer zones between treated areas and surface water bodies, where appropriate.
Pogoji registracije morajo po potrebi vključevati ukrepe za zmanjšanje tveganja, kot so varnostni pasovi med območji nanosa in površinskimi vodami.
CAS No 1305-99-3
Št. CAS 1305-99-3
CIPAC No 505
Št. CIPAC 505
Only outdoor uses as rodenticide in the form of ready-to-use calcium phosphide containing products may be authorised.
Registrira se lahko samo kot rodenticid v obliki proizvodov, ki so pripravljeni za uporabo in vsebujejo kalcijev fosfid.
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on calcium phosphide, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 28 October 2008 shall be taken into account.
Za izvajanje enotnih načel iz Priloge VI se upoštevajo sklepi poročila o pregledu za kalcijev fosfid ter zlasti dodatkov I in II h končni različici poročila, ki jo je Stalni odbor za prehranjevalno verigo in zdravje živali pripravil 28. oktobra 2008.
CAS No 12057-74-8
Št. CAS 12057-74-8
CIPAC No 228
Št. CIPAC 228
Only uses as insecticide and rodenticide in the form of ready-to-use magnesium phosphide containing products may be authorised.
Registrira se lahko samo kot insekticid in rodenticid v obliki proizvodov, ki so pripravljeni za uporabo in vsebujejo magnezijev fosfid.
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on magnesium phosphide, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 28 October 2008 shall be taken into account.
Za izvajanje enotnih načel iz Priloge VI se upoštevajo sklepi poročila o pregledu za magnezijev fosfid ter zlasti dodatkov I in II h končni različici poročila, ki jo je Stalni odbor za prehranjevalno verigo in zdravje živali pripravil 28. oktobra 2008.
the protection of consumers and ensure that the spent ready-to-use magnesium phosphide containing products are removed from the food commodity in uses against storage pests and subsequently an adequate additional withholding period is applied;
varstvo potrošnikov in zagotoviti, da se izrabljeni proizvodi, ki so pripravljeni za uporabo in vsebujejo magnezijev fosfid, pri uporabah proti škodljivcem v skladiščih odstranijo iz živila in da se naknadno uvede ustrezno dodatno obdobje prepovedi uporabe;
the operator safety and ensure that conditions of use prescribe the application of adequate personal and respiratory protective equipment;
varnost izvajalcev tretiranja ter zagotovitev, da je v pogojih uporabe predpisana uporaba ustrezne osebne zaščitne opreme in opreme za zaščito dihal;
CAS No 57966-95-7
Št. CAS 57966-95-7
CIPAC No 419
Št. CIPAC 419
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on cymoxanil, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 28 October 2008 shall be taken into account.
Za izvajanje enotnih načel iz Priloge VI se upoštevajo sklepi poročila o pregledu za cimoksanil ter zlasti dodatkov I in II h končni različici poročila, ki jo je Stalni odbor za prehranjevalno verigo in zdravje živali pripravil 28. oktobra 2008.
the operator and worker safety and ensure that conditions of use prescribe the application of adequate personal protective equipment;
varnost izvajalcev tretiranja in delavcev ter zagotovitev, da je v pogojih uporabe predpisana uporaba ustrezne osebne zaščitne opreme,
the protection of the groundwater, when the active substance is applied in regions with vulnerable soil and/or climatic conditions;
zaščito podtalnice, kadar se aktivna snov uporablja na območjih z občutljivimi tlemi in/ali podnebnimi razmerami,
the protection of aquatic organisms and must ensure that the conditions of authorisation include risk mitigation measures such as buffer zones, where appropriate.
zaščito vodnih organizmov in zagotovitev, da pogoji registracije po potrebi vključujejo potrebne ukrepe za zmanjšanje tveganja, kot so varnostni pasovi.
CAS No 1593-77-7
Št. CAS 1593-77-7
CIPAC No 300
Št. CIPAC 300
Only uses as fungicide on ornamentals in glasshouse may be authorised.
Registrira se lahko samo kot fungicid za okrasne rastline v rastlinjaku.
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on dodemorph, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 28 October 2008 shall be taken into account.
Za izvajanje enotnih načel iz Priloge VI se upoštevajo sklepi poročila o pregledu za dodemorf ter zlasti dodatkov I in II h končni različici poročila, ki jo je Stalni odbor za prehranjevalno verigo in zdravje živali pripravil 28. oktobra 2008.